Gen QA

MEMBER LOGIN

MENU menu

Close close menu

Breast cancer

BACK TO EQA DIRECTORY

Molecular testing of breast cancers for PIK3CA and ESR1 variants in FFPE and cfDNA

EQA INFORMATION

EQA Code
TBCP
Submission
Clinical Report
Techniques
Any methodology
Eligibility
All laboratories worldwide
Language
English, French, German, Italian, Polish, Portuguese, Spanish
EQA Accreditation
EQA accredited to ISO 17043:2010
Timeline: Sample dispatch
Timeline: Testing period
6 weeks

OTHER INFORMATION

 What are participants required to do?
  • Enrolled participants will receive details by email when an EQA is open for assessment and/or samples have been dispatched.  
  • Participants are expected to access the instructions and information for the cases/samples online and to analyse them according to their laboratory/centre protocols. 
  • Participants must submit their anonymised results by the deadline using their standard laboratory report or a proforma provided by GenQA.  The submitted results are independently assessed for the accuracy of the analytical/genotyping results, clinical interpretation of the results (if appropriate) and clerical accuracy (including report layout and content). 

What can I expect as a participant?
Every participant will receive:
  • An Individual Laboratory/Centre Report (ILR/ICR) with educational advice for each distribution of this EQA.
  • The Summary report for each distribution of this EQA which contains information regarding general findings, a summary of methodologies used, common errors, number of participants and benchmarking. 
  • Access to a live Performance Certificate summarising your performance status for all EQAs in which you are enrolled.

Please note: EQA details may be subject to change prior to EQA distribution. 

PRODUCTS

Sample type: FFPE (Formalin Fixed Paraffin Embedded sections), Plasma: artificial
Testing/analysis: Any
This EQA will consist of samples of both FFPE and artificial plasma. Laboratories can choose whether to test either sample type or both, the samples will all represent different cases. 
Conditions/Gene target(s):
  • Breast cancer
  • PIK3CA
  • ESR1
Number of cases: Two

PURCHASE NOW

 

ASK A QUESTION

Breast cancer

Enter your details here: